Kai C. Ngan
P.r, P.r
China
China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Cross-Platform Gene Signature to Predict Survival Outcomes for Nasopharyngeal Carcinoma.
Journal: JCO precision oncology
Published: July 01, 2026
Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: December 15, 2023
An electro-osmotic microfluidic system to characterize cancer cell migration under confinement.
Journal: Journal of the Royal Society, Interface
Published: June 06, 2019
Crucifera sulforaphane (SFN) inhibits the growth of nasopharyngeal carcinoma through DNA methyltransferase 1 (DNMT1)/Wnt inhibitory factor 1 (WIF1) axis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 10, 2018
Cadherin- and Rigidity-Dependent Growth of Lung Cancer Cells in a Partially Confined Microenvironment.
Journal: ACS biomaterials science & engineering
Published: February 12, 2018
Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 21, 2016
Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma.
Journal: Oncotarget
Published: June 21, 2016
Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 09, 2016
Regulating the Membrane Transport Activity and Death of Cells via Electroosmotic Manipulation.
Journal: Biophysical journal
Published: December 09, 2015
NF-κB p65 Subunit Is Modulated by Latent Transforming Growth Factor-β Binding Protein 2 (LTBP2) in Nasopharyngeal Carcinoma HONE1 and HK1 Cells.
Journal: PloS one
Published: December 18, 2014
Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.
Journal: Scientific reports
Published: November 02, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026